Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clare L Scott

Showing results (31-40 of 110) with videos related to

Pageof 11
Sort By:
JNCI Cancer Spectrum|October 21, 2024
Impact of chemotherapy on patients with mismatch repair deficient advanced endometrial carcinomas-a meta-analysisAngelina Tjokrowidjaja, Peey-Sei Kok, Yoland C Antill, et al.
Genes & Development|August 4, 2010
Apoptosis-promoted tumorigenesis: gamma-irradiation-induced thymic lymphomagenesis requires Puma-driven leukocyte deathEwa M Michalak, Cassandra J Vandenberg, Alex R D Delbridge, et al.
Histopathology|November 5, 2020
Primary mucinous ovarian neoplasms rarely show germ cell histogenesisFelix K F Kommoss, Dane Cheasley, Matthew J Wakefield, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 14, 2008
In vivo efficacy of the Bcl-2 antagonist ABT-737 against aggressive Myc-driven lymphomasKylie D Mason, Cassandra J Vandenberg, Clare L Scott, et al.
Cancer Research|March 28, 2020
RNF168-Mediated Ubiquitin Signaling Inhibits the Viability of <i>BRCA1</i>-Null CancersJohn J Krais, Yifan Wang, Andrea J Bernhardy, et al.
Blood|July 16, 2010
Elevated Mcl-1 perturbs lymphopoiesis, promotes transformation of hematopoietic stem/progenitor cells, and enhances drug resistanceKirsteen J Campbell, Mary L Bath, Marian L Turner, et al.
NAR Cancer|July 26, 2024
High-level tumour methylation of <i>BRCA1</i> and <i>RAD51C</i> is required for homologous recombination deficiency in solid cancersLijun Xu, Brett Liddell, Ksenija Nesic, et al.
The Journal of Biological Chemistry|February 6, 2010
c-Cbl promotes T cell receptor-induced thymocyte apoptosis by activating the phosphatidylinositol 3-kinase/Akt pathwayChristine B F Thien, Samantha A Dagger, James H Steer, et al.
Cell Reports|May 14, 2013
p53 efficiently suppresses tumor development in the complete absence of its cell-cycle inhibitory and proapoptotic effectors p21, Puma, and NoxaLiz J Valente, Daniel H D Gray, Ewa M Michalak, et al.
Journal of Gynecologic Oncology|October 28, 2021
Insights into ovarian cancer care: report from the ANZGOG Ovarian Cancer Webinar Series 2020Andreas Obermair, Philip Beale, Clare L Scott, et al.
Pageof 11

Showing results (31-40 of 110) with videos related to

Sort By:
Pageof 11
JNCI Cancer Spectrum|October 21, 2024
Impact of chemotherapy on patients with mismatch repair deficient advanced endometrial carcinomas-a meta-analysisAngelina Tjokrowidjaja, Peey-Sei Kok, Yoland C Antill, et al.
Genes & Development|August 4, 2010
Apoptosis-promoted tumorigenesis: gamma-irradiation-induced thymic lymphomagenesis requires Puma-driven leukocyte deathEwa M Michalak, Cassandra J Vandenberg, Alex R D Delbridge, et al.
Histopathology|November 5, 2020
Primary mucinous ovarian neoplasms rarely show germ cell histogenesisFelix K F Kommoss, Dane Cheasley, Matthew J Wakefield, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 14, 2008
In vivo efficacy of the Bcl-2 antagonist ABT-737 against aggressive Myc-driven lymphomasKylie D Mason, Cassandra J Vandenberg, Clare L Scott, et al.
Cancer Research|March 28, 2020
RNF168-Mediated Ubiquitin Signaling Inhibits the Viability of <i>BRCA1</i>-Null CancersJohn J Krais, Yifan Wang, Andrea J Bernhardy, et al.
Blood|July 16, 2010
Elevated Mcl-1 perturbs lymphopoiesis, promotes transformation of hematopoietic stem/progenitor cells, and enhances drug resistanceKirsteen J Campbell, Mary L Bath, Marian L Turner, et al.
NAR Cancer|July 26, 2024
High-level tumour methylation of <i>BRCA1</i> and <i>RAD51C</i> is required for homologous recombination deficiency in solid cancersLijun Xu, Brett Liddell, Ksenija Nesic, et al.
The Journal of Biological Chemistry|February 6, 2010
c-Cbl promotes T cell receptor-induced thymocyte apoptosis by activating the phosphatidylinositol 3-kinase/Akt pathwayChristine B F Thien, Samantha A Dagger, James H Steer, et al.
Cell Reports|May 14, 2013
p53 efficiently suppresses tumor development in the complete absence of its cell-cycle inhibitory and proapoptotic effectors p21, Puma, and NoxaLiz J Valente, Daniel H D Gray, Ewa M Michalak, et al.
Journal of Gynecologic Oncology|October 28, 2021
Insights into ovarian cancer care: report from the ANZGOG Ovarian Cancer Webinar Series 2020Andreas Obermair, Philip Beale, Clare L Scott, et al.
Pageof 11